Literature DB >> 19500737

Risk factors for esophageal cancer development.

Gary W Falk1.   

Abstract

The incidence of esophageal adenocarcinoma is increasing at a rate greater than that of any other cancer in the Western world today. Barrett's esophagus is a clearly recognized risk factor for the development of esophageal adenocarcinoma, but the overwhelming majority of patients with Barrett's esophagus will never develop esophageal cancer. To date, dysplasia remains the only factor useful for identifying patients at increased risk for the development of esophageal adenocarcinoma in clinical practice. Other epidemiologic risk factors include aging, gender, race, obesity, reflux symptoms, smoking, and diet. Factors that may protect against the development of adenocarcinoma include infection with Helicobacter pylori, a diet rich in fruits and vegetables, and consumption of aspirin and NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500737     DOI: 10.1016/j.soc.2009.03.005

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  40 in total

Review 1.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

Review 2.  Polyphenols and aging.

Authors:  Brannon L Queen; Trygve O Tollefsbol
Journal:  Curr Aging Sci       Date:  2010-02

3.  The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid.

Authors:  Heather B Roesly; Mohammad R Khan; Hwu Dau Rw Chen; Kimberly A Hill; Nirushan Narendran; George S Watts; Xiaoxin Chen; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-02       Impact factor: 4.052

4.  Label-free multi-photon imaging of dysplasia in Barrett's esophagus.

Authors:  Soroush Mehravar; Bhaskar Banerjee; Hemant Chatrath; Babak Amirsolaimani; Krunal Patel; Charmi Patel; Robert A Norwood; Nasser Peyghambarian; Khanh Kieu
Journal:  Biomed Opt Express       Date:  2015-12-16       Impact factor: 3.732

5.  Reply to letter to the editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First).

Authors:  Sri Ganeshamurthy Thrumurthy; Christopher John Lewis; Susan Pritchard; Gordon Armstrong; Stephen Edwin Arthur Attwood
Journal:  Surg Endosc       Date:  2012-01       Impact factor: 4.584

6.  Does immigration play a role in the risk of gastric cancer by site and by histological type? A study of first-generation immigrants in Sweden.

Authors:  Seyed Mohsen Mousavi; Jan Sundquist; Kari Hemminki
Journal:  Gastric Cancer       Date:  2011-03-23       Impact factor: 7.370

7.  Confocal foveated endomicroscope for the detection of esophageal carcinoma.

Authors:  Adam Shadfan; Anne Hellebust; Rebecca Richards-Kortum; Tomasz Tkaczyk
Journal:  Biomed Opt Express       Date:  2015-06-03       Impact factor: 3.732

8.  Impact of enhanced recovery program on patients with esophageal cancer in comparison with traditional care.

Authors:  Lihong Wang; Chenjing Zhu; Xuelei Ma; Kai Shen; Hongmei Li; Yuanyuan Hu; Linghong Guo; Jing Zhang; Ping Li
Journal:  Support Care Cancer       Date:  2016-10-10       Impact factor: 3.603

9.  Esophageal cancer in Canada: trends according to morphology and anatomical location.

Authors:  Michael C Otterstatter; James D Brierley; Prithwish De; Larry F Ellison; Maureen Macintyre; Loraine D Marrett; Robert Semenciw; Hannah K Weir
Journal:  Can J Gastroenterol       Date:  2012-10       Impact factor: 3.522

10.  Amiloride and guggulsterone suppression of esophageal cancer cell growth in vitro and in nude mouse xenografts.

Authors:  Baoxiang Guan; Ashraful Hoque; Xiaochun Xu
Journal:  Front Biol (Beijing)       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.